Who
Sudarshan Hebbar
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, CalciMedica.
In numbers
- Trades disclosed
- 36
- Buys
- 5
- Sells
- 0
- Bought
- $169K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 20 Mar 2023
- Last trade
- 24 Sep 2026
- Last filed
- 28 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Sep 2026filed 28 Sep 2026 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —180,000 at $0.00 | filing |
| 24 Sep 2026filed 28 Sep 2026 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —180,000 at $0.00 | filing |
| 19 Aug 2026filed 21 Aug 2026 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —124,486 at $0.00 | filing |
| 19 Aug 2026filed 21 Aug 2026 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —124,486 at $0.00 | filing |
| 19 Aug 2026filed 21 Aug 2026 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —124,486 at $0.00 | filing |
| 19 Aug 2026filed 21 Aug 2026 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —124,486 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | CALC CalciMedicaBiotechnology | SEC FORM 4 Code A | $100K124,486 at $0.8033 | filing |
| 25 Jun 2026filed 29 Jun 2026 | CALC CalciMedicaBiotechnology | SEC FORM 4 Code A | $100K124,486 at $0.80 | filing |
| 19 Aug 2025filed 21 Aug 2025 | CALC CalciMedicaBiotechnology | SEC FORM 4 Bought | $27K9,563 at $2.82 | filing |
| 15 Aug 2025filed 18 Aug 2025 | CALC CalciMedicaBiotechnology | SEC FORM 4 Bought | $12K4,392 at $2.79 | filing |
| 14 Aug 2025filed 18 Aug 2025 | CALC CalciMedicaBiotechnology | SEC FORM 4 Bought | $4,1031,584 at $2.59 | filing |
| 24 Jun 2025filed 26 Jun 2025 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —83,300 at $0.00 | filing |
| 23 Apr 2025filed 25 Apr 2025 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —175,000 at $0.00 | filing |
| 5 Apr 2025filed 7 Apr 2026 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —91,173 at $0.00 | filing |
| 5 Apr 2025filed 7 Apr 2026 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —91,173 at $0.00 | filing |
| 27 Aug 2024filed 28 Aug 2024 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —82,500 at $0.00 | filing |
| 28 Mar 2024filed 22 Apr 2024 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —82,500 at $0.00 | filing |
| 3 Nov 2023filed 7 Nov 2023 | CALC CalciMedicaBiotechnology | SEC FORM 4 Bought | $99K36,000 at $2.74 | filing |
| 16 May 2023filed 18 May 2023 | CALC CalciMedicaBiotechnology | SEC FORM 4 Bought | $27K10,000 at $2.70 | filing |
| 8 May 2023filed 10 May 2023 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,709 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.